Table 7 of Nasir, Mol Vis 2014; 20:822-835.

Table 7. Effect of microemulsion and liposomal formulation of tocotrienol (0.03%) on the lenticular MDA, GSH, CAT and SOD during 4 weeks period of treatment (Study 2: anticataract efficacy of microemulsion versus liposome).

Groups Lens MDA (µmol/g lens weight) Lens GSH (µmol/g lens weight) Lens CAT (µmol/g lens protein) Lens SOD (Units/mg lens protein)
Normal 60.26±7.1 5.00±1.4 86.63±29.9 9.41±1.8
VE 81.24±12.8 a 0.48±0.1 a 36.73±14.4 a 5.16±1.3 a
VL 95.28±19.3 a 0.48±0.1 a 35.29±6.9 a 5.23±1.2 a
0.03% TTE 53.04±15.2 b 1.02±0.5 a, b 85.12±13.9 b 10.13±3.0 b
0.03% TTL 61.94±7.0 c 1.16±0.2 a, c 82.33±26.5 c 11.98±5.8 c

All values are mean ± SD (n=6). ap<0.05 versus normal; bp<0.05 versus VE; cp<0.05 versus VL. MDA- malondialdehyde; GSH- reduced glutathione; CAT- catalase; SOD – superoxide dismutase; VE – vehicle for microemulsion; VL – vehicle for liposomes; TTE – tocotrienol in microemulsion; TTL – tocotrienol in liposomal formulation.

Nasir, Mol Vis 2014; 20:822-835. http://www.molvis.org/molvis/v20/822

©2014 Molecular Vision http://www.molvis.org/molvis/

ISSN 1090-0535